FDA Recommends An Additional Booster Shot For Those Over 50

March 29, 2022 6:25 pm Published by

It is never an easy thing for a federal government agency to make recommendations around science that is continuing to be understood, but the U.S. Food and Drug Administration (FDA) did just that today with the announcement that they will be recommending an additional booster shot of the COVID-19 vaccine for those individuals who are 50 years old or older as well as those that are immunocompromised.

This recommendation is considered by many as a first sign that there may be waning efficacy of the initial COVID-19 vaccine as well as the booster shots that many in this age group had received just a few short months ago. The recommendation is that anyone who has received their booster shot four months ago or earlier should seek to get another booster shot if over the age of 50 or immunocompromised.

While there is limited scientific data to suggest that the efficacy of the first three shots are waning, there is concern by some that another wave of COVID-19 could be winding up here in the United States and therefore as an added layer of protection these groups should be among the first to receive another dose of the vaccine.

The United States Centers for Disease Control (CDC) is expected to make a formal recommendation sometime today or tomorrow to give complete guidance on exactly who should get an additional booster shot and when they should get it, but that guidance is not yet available.

The FDA is making this recommendation due in large part to a perceived waning of efficacy of the original shots and also as a stop gap going into the fall when it is likely that all eligible residents will need an additional shot. It is the hope of some in the scientific community that scientists will have been able to develop a vaccine that is more effective on COVID-19 variants by the time that an additional shot is needed for all Americans.